Context: Male infertility has been associated with increased morbidity and mortality. Objective: To perform a systematic review and meta-analysis to provide the most critical evidence on the association between infertility and the risk of incident comorbidities in males. Evidence acquisition: A systematic review and meta-analysis was performed according to the Meta-analysis of Observational Studies in Epidemiology and Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, and registered on PROSPERO. All published studies on infertile versus fertile men regarding overall mortality and risks of cancer, diabetes, and cardiovascular events were selected from a database search on PubMed, EMBASE, Google Scholar, and Cochrane. Forest plot and quasi-individual patient data meta-analysis were used for pooled analyses. A risk of bias was assessed using the ROBINS-E tool. Evidence synthesis: Overall, an increased risk of death from any cause was found for infertile men (hazard risk [HR] 1.37, [95% confidence interval {CI} 1.04–1.81], p = 0.027), and a 30-yr survival probability of 91.0% (95% CI 89.6–92.4%) was found for infertile versus 95.9% (95% CI 95.3–96.4%) for fertile men (p < 0.001). An increased risk emerged of being diagnosed with testis cancer (relative risk [RR] 1.86 [95% CI 1.41–2.45], p < 0.001), melanoma (RR 1.30 [95% CI 1.08–1.56], p = 0.006), and prostate cancer (RR 1.66 [95% CI 1.06–2.61], p < 0.001). As well, an increased risk of diabetes (HR 1.39 [95% CI 1.09–1.71], p = 0.008), with a 30-yr probability of diabetes of 25.0% (95% CI 21.1–26.9%) for infertile versus 17.1% (95% CI 16.1–18.1%) for fertile men (p < 0.001), and an increased risk of cardiovascular events (HR 1.20 [95% CI 1.00–1.44], p = 0.049), with a probability of major cardiovascular events of 13.9% (95% CI 13.3–14.6%) for fertile versus 15.7% (95% CI 14.3–16.9%) for infertile men (p = 0.008), emerged. Conclusions: There is statistical evidence that a diagnosis of male infertility is associated with increased risks of death and incident comorbidities. Owing to the overall high risk of bias, results should be interpreted carefully. Patient summary: Male fertility is a proxy of general men's health and as such should be seen as an opportunity to improve preventive strategies for overall men's health beyond the immediate reproductive goals.
A Systematic Review and Meta-analysis on the Impact of Infertility on Men's General Health / Fallara, G.; Pozzi, E.; Belladelli, F.; Boeri, L.; Capogrosso, P.; Corona, G.; D'Arma, A.; Alfano, M.; Montorsi, F.; Salonia, A.. - In: EUROPEAN UROLOGY FOCUS. - ISSN 2405-4569. - 10:1(2024), pp. 98-106. [10.1016/j.euf.2023.07.010]
A Systematic Review and Meta-analysis on the Impact of Infertility on Men's General Health
Fallara G.;Pozzi E.;Belladelli F.;Montorsi F.;Salonia A.
2024-01-01
Abstract
Context: Male infertility has been associated with increased morbidity and mortality. Objective: To perform a systematic review and meta-analysis to provide the most critical evidence on the association between infertility and the risk of incident comorbidities in males. Evidence acquisition: A systematic review and meta-analysis was performed according to the Meta-analysis of Observational Studies in Epidemiology and Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, and registered on PROSPERO. All published studies on infertile versus fertile men regarding overall mortality and risks of cancer, diabetes, and cardiovascular events were selected from a database search on PubMed, EMBASE, Google Scholar, and Cochrane. Forest plot and quasi-individual patient data meta-analysis were used for pooled analyses. A risk of bias was assessed using the ROBINS-E tool. Evidence synthesis: Overall, an increased risk of death from any cause was found for infertile men (hazard risk [HR] 1.37, [95% confidence interval {CI} 1.04–1.81], p = 0.027), and a 30-yr survival probability of 91.0% (95% CI 89.6–92.4%) was found for infertile versus 95.9% (95% CI 95.3–96.4%) for fertile men (p < 0.001). An increased risk emerged of being diagnosed with testis cancer (relative risk [RR] 1.86 [95% CI 1.41–2.45], p < 0.001), melanoma (RR 1.30 [95% CI 1.08–1.56], p = 0.006), and prostate cancer (RR 1.66 [95% CI 1.06–2.61], p < 0.001). As well, an increased risk of diabetes (HR 1.39 [95% CI 1.09–1.71], p = 0.008), with a 30-yr probability of diabetes of 25.0% (95% CI 21.1–26.9%) for infertile versus 17.1% (95% CI 16.1–18.1%) for fertile men (p < 0.001), and an increased risk of cardiovascular events (HR 1.20 [95% CI 1.00–1.44], p = 0.049), with a probability of major cardiovascular events of 13.9% (95% CI 13.3–14.6%) for fertile versus 15.7% (95% CI 14.3–16.9%) for infertile men (p = 0.008), emerged. Conclusions: There is statistical evidence that a diagnosis of male infertility is associated with increased risks of death and incident comorbidities. Owing to the overall high risk of bias, results should be interpreted carefully. Patient summary: Male fertility is a proxy of general men's health and as such should be seen as an opportunity to improve preventive strategies for overall men's health beyond the immediate reproductive goals.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
